(Q57998575)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Chiara de Waure

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Valentina Ambrosini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Paola Castaldi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Maria Felicia Villani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Germano Perotti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Angelina Filice

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nadia Cremonini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Monica Santimaria

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Annibale Versari

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Stefano Fanti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Alessandro Giordano

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Vittoria Rufini

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

6 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

number of pages

12

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

569-580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-011-2031-6

19 January 2020

exact match

0 references

cites work

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Medullary thyroid cancer: management guidelines of the American Thyroid Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

New therapeutic approaches to treat medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Imaging of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET/CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-2031-6

Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer

21 January 2018

1 reference

12 December 2020

Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma

1 reference

12 December 2020

FDG-PET: procedure guidelines for tumour imaging

1 reference

12 December 2020

Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas

1 reference

12 December 2020

The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer

1 reference

12 December 2020

Medullary thyroid carcinoma

1 reference

12 December 2020

Somatostatin receptors and somatostatin content in medullary thyroid carcinomas

1 reference

12 December 2020

Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma

1 reference

12 December 2020

18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma

1 reference

12 December 2020

Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?

1 reference

12 December 2020

Role of PET in medullary thyroid carcinoma

1 reference

12 December 2020

The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid

1 reference

12 December 2020

Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen

1 reference

12 December 2020

Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels

1 reference

12 December 2020

10.1007/S00259-011-2031-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22223169%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference